Treatment with agalsidase beta during pregnancy in Fabry disease

Journal of Obstetrics and Gynaecology Research

Volumn 36, Issue 2, 2010, Pages 428-429

  Politei, Juan M ^a  

^a HOSPITAL JUAN A FERNÁNDEZ   (Argentina)

Author keywords

Agalsidase beta; Fabry disease; Pregnancy

Indexed keywords

AGALSIDASE BETA;

ADULT; ANEMIA; ARTICLE; BLOOD EXAMINATION; CASE REPORT; DISEASE COURSE; ECHOCARDIOGRAPHY; FABRY DISEASE; FAMILY HISTORY; FATIGUE; FEMALE; HEMANGIOKERATOMA; HUMAN; MISSENSE MUTATION; PARESTHESIA; PREGNANCY DISORDER; SYNCOPE; URINALYSIS; VAGINAL DELIVERY;

ALPHA-GALACTOSIDASE; ENZYME REPLACEMENT THERAPY; FABRY DISEASE; FEMALE; HUMANS; ISOENZYMES; PREGNANCY; PREGNANCY OUTCOME; TREATMENT OUTCOME;

EID: 77950294231     PISSN: 13418076     EISSN: 14470756     Source Type: Journal    
DOI: 10.1111/j.1447-0756.2009.01164.x     Document Type: Article

References (9)

1. Desnick R, Brady R, Barranger J et al. Fabry disease, an under-recognized multisystemic disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy. Ann Intern Med 2003 138 : 338 346.
2. Maier EM, Osterrieder S, Whybra C et al. Disease manifestations and X inactivation in heterozygous females with Fabry disease. Acta Paediatr Suppl 2006 95 : 30 38.
3. Schiffmann R, Kopp JB, Austin HA III. et al. Enzyme replacement therapy in Fabry disease: a randomized controlled trial. JAMA 2001 285 : 2743 2749.
4. Eng CM, Guffon N, Wilcox WR et al. Safety and efficacy of recombinant human α-galactosidase A - replacement therapy in Fabry's disease. N Engl J Med 2001 345 : 9 16.
5. Wilcox W, Oliveira J, Hopkin R et al. Females with Fabry disease frequently have major organ involvement: Lessons from the Fabry Registry. Mol Genet Metabolism 2008 93 : 112 128.
6. Wendt S, Whybra C, Kampmann C, Teichmann E, Beck M. Successful pregnancy outcome in a patient with Fabry disease receiving enzyme replacement therapy with agalsidase alfa. J Inherit Metab Dis 2005 28 : 787 788.
7. Kalkum G, Macchiella D, Reinke J, Kölbl H, Beck M. Enzyme replacement therapy with agalsidase alfa in pregnant women with Fabry disease. Eur J Obstet Gynecol Reprod Biol 2009.
8. Vedder A, Strijland A, Bergh Weerman M, Florquin S, Aerts J, Hollak C. Manifestations of Fabry disease in placental tissue. J Inherit Metab Dis 2006 29 : 106 111.
9. Popli S, Leehey D, Molnar Z, Nawab Z, Ing T. Demonstration of Fabry's disease deposits in placenta. Am J Obstet Gynecol 1990 162 : 464 465.